Tumour burden and local treatment access determine colorectal cancer outcomes rather than timing of liver metastases ...

Scientists at the University of Science and Technology of China have identified a signaling chain that starts with gut ...

Liver disease is a major global health problem, causing over two million deaths worldwide each year. While animal models have helped to understand liver biology, they often fail to accurately ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

The MarketWatch News Department was not involved in the creation of this content. Recipients of ALF 's Pilot, Liver Scholar, Postdoctoral, and Travel Awards offer Groundbreaking Possibilities ...

Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup. More than 100 million people in the United States suffer from metabolic ...

A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.

Human periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders are delineated in ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...

ALF's Liver Scholar Awards provide five junior faculty selected in 2023 and 2024 with three-years of funding for their research and supports the development of early career scientists in liver biology ...